These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21206864)

  • 61. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials.
    Luan S; Wan H; Wang S; Li H; Zhang B
    Neuropsychiatr Dis Treat; 2017; 13():609-620. PubMed ID: 28280343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel augmentation strategy for treating resistant major depression.
    Shelton RC; Tollefson GD; Tohen M; Stahl S; Gannon KS; Jacobs TG; Buras WR; Bymaster FP; Zhang W; Spencer KA; Feldman PD; Meltzer HY
    Am J Psychiatry; 2001 Jan; 158(1):131-4. PubMed ID: 11136647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV; Dellva MA; Tollefson GD; Beasley CM; Potvin JH; Kiesler GM
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment algorithms in treatment-resistant depression.
    Amsterdam JD; Hornig-Rohan M
    Psychiatr Clin North Am; 1996 Jun; 19(2):371-86. PubMed ID: 8827195
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tardive dyskinesia.
    Jeste DV; Caligiuri MP
    Schizophr Bull; 1993; 19(2):303-15. PubMed ID: 8100643
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacotherapy of delusional depression: experience with combinations of antidepressants with the neuroleptics zotepine and haloperidol.
    Wolfersdorf M; König F; Straub R
    Neuropsychobiology; 1994; 29(4):189-93. PubMed ID: 7914009
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Major tranquillisers used as antidepressants. A review.
    Robertson MM; Trimble MR
    J Affect Disord; 1982 Sep; 4(3):173-93. PubMed ID: 6127357
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tricyclic nonresponders: phenomenology and treatment.
    Roose SP; Glassman AH; Walsh BT; Woodring S
    Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Olanzapine and fluoxetine combination in severe or resistant depression.
    Haridas RM; Parkar SR; Ghulam R; Amin G; Thombre KG; Srivastava A; Bhuvaneshwari N; Telang S; Obrah M; Toraskar N; Jalali RK; Marthak KV
    Indian J Psychiatry; 2003 Oct; 45(4):234-8. PubMed ID: 21206864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spotlight on olanzapine/fluoxetine in acute bipolar depression.
    Deeks ED; Keating GM
    CNS Drugs; 2008; 22(9):793-5. PubMed ID: 18698877
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
    Deeks ED; Keating GM
    Drugs; 2008; 68(8):1115-37. PubMed ID: 18484802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.